Related Experiment Video
Updated: May 3, 2026

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
Published on: November 3, 2023
Gastrointestinal bleeding in hospitalized children in the United States
Chaitanya Pant1, Senthilkumar Sankararaman, Abhishek Deshpande
1Department of Medicine, Kansas University Medical Center , Kansas City, KS , USA.
Insights
Gastrointestinal (GI) bleeding affects 0.5% of hospitalized children in the US, with older males and those with severe illness at higher risk. This condition significantly increases mortality risk in pediatric patients.
Area of Science:
- Pediatric Gastroenterology
- Epidemiology
- Healthcare Research
Background:
- Gastrointestinal (GI) bleeding is a significant concern in pediatric healthcare.
- Understanding the epidemiology of GI bleeding in hospitalized children is crucial for effective management and resource allocation.
Purpose of the Study:
- To investigate the epidemiology of GI bleeding in hospitalized children in the United States.
- To identify demographic, clinical, and outcome-related factors associated with pediatric GI bleeding.
Main Methods:
- Utilized the Healthcare Cost and Utilization Project Kids' Inpatient Database (2009) for national-level estimates.
- Analyzed 23,383 pediatric discharges with GI bleeding diagnoses.
- Compared characteristics and outcomes of children with and without GI bleeding.
Main Results:
- GI bleeding accounted for 0.5% of pediatric hospitalizations.
- Children with GI bleeding were more likely to be male, older (≥11 years), and have higher comorbidity and severity of illness.
- Incidence was highest in children aged 11-15 years, with blood in stool and hematemesis being common presentations. Mortality risk was elevated, particularly in perforation cases.
Conclusions:
- GI bleeding represents a substantial burden in hospitalized children, associated with increased mortality.
- Findings highlight specific risk factors and presentations, informing clinical attention.
- Study limitations include reliance on administrative codes and exclusion of non-hospitalized children.
Objective:
To investigate the epidemiology of GI bleeding in hospitalized children in the United States.
Methods:
Data were obtained from the Healthcare Cost and Utilization Project Kids' Inpatient Database, Agency for Healthcare Research and Quality for the year 2009. The data were weighted to generate national-level estimates.
Results:
There were 23,383 pediatric discharges with a diagnosis of GI bleeding accounting for 0.5% of all discharges. Children with a GI bleed compared to those without were more likely to be male (54.5% vs. 45.8%; P < 0.001), older (children ≥11 years; 50.8% vs. 38.7%; P < 0.001), and admitted to a teaching hospital (70.5% vs. 56.4%; P < 0.001). Children 11-15 years of age had the highest incidence of GI bleeding (84.2 per 10,000 discharges) and children less than 1 year of age the lowest (24.4 per 10,000 discharges). The highest incidence of GI bleeding was attributable to cases coded as blood in stool (17.6 per 10,000 discharges) followed by hematemesis (11.2 per 10,000 discharges). Those with a GI bleed had a higher co-morbid burden (12.3% vs. 2.3%; P < 0.001) and severity of illness (40.1% vs. 14.5%; P < 0.001). The highest mortality rates associated with GI bleeding were observed in cases with intestinal perforation (8.7%) and esophageal perforation (8.4%). GI bleeding was independently associated with a higher risk of mortality (aOR 1.68, CI 1.53-1.84).
Conclusions:
Our results describe the epidemiology of GI bleeding in hospitalized children within the United States. We found a substantial risk of mortality attributable to GI bleeding in this patient population. Our study is limited by the exclusion of non-hospitalized children, the reliance on ICD-9-CM codes and the absence of longitudinal follow up of patients.
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Peptic Ulcer
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Clinical Manifestations
